comparemela.com

Latest Breaking News On - ஹான் செங் - Page 1 : comparemela.com

Вице-премьер Госсовета КНР подчеркнул важность создания ориентированной на рынок и интернационализированной деловой среды, основанной на верховенстве закона_Russian news cn

Вице-премьер Госсовета КНР подчеркнул важность создания ориентированной на рынок и интернационализированной деловой среды, основанной на верховенстве закона_Russian news cn
russian.news.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from russian.news.cn Daily Mail and Mail on Sunday newspapers.

MSM, FGV, AAX, Tri-Mode Systems, Nestcon, Destini, Pasukhas, CMSB, Key Alliance and Macpie

Based on corporate announcements and news flow today, companies in focus on Friday (Sept 17) may include: MSM Malaysia Holdings Bhd, FGV Holdings Bhd, AirAsia X Bhd, Tri-Mode Systems (M) Bhd, Nestcon Bhd, Destini Bhd, Pasukhas Group Bhd, Cahya Mata Sarawak Bhd (CMSB), Key Alliance Group Bhd and Macpie Bhd.

CSSB sells land in Pulau Indah Industrial Park to Tri-Mode for RM17m | Money

KUALA LUMPUR, Aug 13 Central Spectrum (M) Sdn Bhd (CSSB) inked a deal with Tri-Mode System (M) Bhd today for the disposal of a 2.18-hectare industrial land in Pulau Indah Industrial Park, Phase 3C (PIIP 3C) for RM17 million. CSSB, the master developer of Pulau Indah Industrial Park and owned by.

China to soon approve mRNA Covid-19 vaccine

BEIJING (The Straits Times/ANN): China s drug regulator is set to give the green light for the first foreign-made mRNA vaccine. Shanghai-based Fosun Pharma said the National Medical Products Administration (NMPA) recently completed an expert panel review of an mRNA Covid-19 vaccine co-developed between the company and German firm BioNTech. Named BNT162b2, the vaccine is internationally known as the Pfizer-BioNTech vaccine, or by its brand name, Comirnaty, which is being administered in many countries around the world, including Singapore. In China, it is referred to as the Fosun-BioNTech vaccine. Last week, Fosun said BNT162b2 was now undergoing an administrative review, and company chairman Wu Yifang told a shareholders meeting that the drugmaker was targeting to start domestic trial production by the end of August.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.